OSL Chart, page-58

Hi Hyper

Yes it was a bit of fun. To be absolutely honest I was never really concerned that Oncosil would go up much higher. Of course as a long term holder I would want it to go higher. But it’s history is important to look at. Retail holders have had a terrible time with this stock for many many years. The stock price is lower today than last year. Broker reports predicted share price of circa 40 cents have also been wrong for many years.

I think many on this forum would agree that this company’s performance has been very disappointing. And I’m being polite here. Some on this forum will have a few more choice words to say.

The other point I would like to make is that management appear to be more concerned with the “scientific” achievements of the Oncosil device. As important as these achievements are, and I know they are important, the share price and returns are also important to shareholders. Let’s repeat what the share price is today. 12 cents. Let that sink in management. It’s 12 cents. Not 20 cents, Not 30 cents nor those 40 cent projections from the Brokers.

This is unsatisfactory from a shareholder perspective. Most of us are not scientists but rather passive investors who have spent a long long time with this company with virtually zero return for years. Again let that sink in. Zero return for years. No dividends, no capital gains, nothing.

Some people will say, we’ll sell up and go. That is a cop out. Shareholders deserve better. Zero returns, year in year out and asked to contribute to 2 capital raisings is not a good enough outcome. Particularly, when many bio tech stocks have been treated and are booming. A number of these biotech stocks have seen large share price increases without producing any revenue. Why is this position different at Oncosil?????